GMAB · NASDAQ · STOCK
Genmab A/S
$30.82
52W $21.17 – $35.43
60/100
$18.94B
24.0
0.69
Is GMAB Bullish or Bearish?
Bullish.
Innellis AI committee rates Genmab A/S (GMAB) Buy with a composite score of 60/100
, based on 5 analysts with 60% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.75 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.25 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull & Bear Case
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.15 across 13 articles, 14d) — News
Bear Case
- EPS declining -25.3% YoY despite any revenue growth — Growth
- RSI at 73 is in overbought territory — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
60/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 45%
of 192 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
neutral
42
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
− EPS declining -25.3% YoY despite any revenue growth
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− RSI at 73 is in overbought territory
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.15 across 13 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
72.5
Overbought
MACD Histogram
0.153
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$30.36
Resistance
$33.65
Bollinger %B
0.97
Inside Bands
Price vs Moving Averages
EMA 9
$29.99
Above
EMA 21
$29.25
Above
EMA 50
$28.29
Above
EMA 200
$27.69
Above
Fundamental Analysis
Valuation
79
Profitability
62
Financial Health
90
Cash Flow
70
Valuation
P/E Ratio
24.0×
P/B Ratio
3.17×
PEG Ratio
-0.28
Dividend Yield
0.00%
52W High
$35.43
52W Low
$21.17
Quality & Growth
ROE
1652.1%
ROA
750.4%
Gross Margin
3991.8%
Operating Margin
1381.2%
Revenue Growth YoY
—
Debt / Equity
0.89
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 24.0 (inexpensive relative to a 15-40x range); Price-to-book of 3.2x; PEG ratio of -0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 16.5%; Return on assets of 7.5%; Net margin of 8.2%; Gross margin of 39.9%; Current ratio of 2.46 (healthy short-term liquidity); Debt-to-equity of 0.89; Free cash flow per share is positive (1.42); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full GMAB Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →